{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:05:24Z","timestamp":1791824724047,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myeloproliferative neoplasms (MPNs) are clonal hematopoietic disorders with variable clinical outcomes influenced by the bone marrow microenvironment. Tumor-associated macrophages (TAMs), particularly the M1 (CD68\u207a) and M2 (CD163\u207a) subtypes, play critical roles in inflammation, fibrosis, and immune modulation. This study evaluates CD68- and CD163-positive macrophage frequencies across MPN subtypes and their clinical\/prognostic significance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cohort study, 121 patients with histopathologically confirmed BCR::ABL1-negative, JAK2V617F-positive MPNs were assessed for CD68 and CD163 expression. The CD68\/CD163 ratio was analyzed for associations with thrombosis, leukemic\/fibrotic transformation, and survival outcomes using receiver operating characteristic (ROC) curves and Kaplan-Meier analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A CD68\/CD163 ratio\u2009&gt;\u20091.63 correlated with shorter thrombosis-free survival (41.4 vs. 68.2 months;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001; hazard ratio [HR] 2.45, 95% confidence interval [CI] 1.45\u20134.14) and secondary myelofibrosis progression-free survival (48.3 vs. 79.0 months;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001; HR 2.67, 95% CI 1.55\u20134.60). The ratio predicted thrombosis (area under the curve [AUC]\u2009=\u20090.677, 95% CI 0.58\u20130.77;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001) and secondary myelofibrosis (AUC\u2009=\u20090.779, 95% CI 0.69\u20130.87;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). CD68 alone showed excellent diagnostic accuracy for the prediction of secondary myelofibrosis (AUC\u2009=\u20090.851, 95% CI 0.78\u20130.92; specificity\u2009=\u2009100%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TAM polarization, reflected by the CD68\/CD163 ratio, is a prognostic marker in MPNs, particularly for thrombosis and fibrotic progression. These findings support integrating TAM profiling into routine histopathology and suggest macrophage-targeted therapies as potential strategies for MPN management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13000-025-01727-x","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T14:20:50Z","timestamp":1763130050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic utility of macrophage polarization (CD68\/CD163 ratio) in Egyptian JAK2 positive myeloproliferative neoplasm patients: a single center study"],"prefix":"10.1186","volume":"20","author":[{"given":"Shirihan Mahmoud Anwar","family":"Mahgoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa Salah Mohamed","family":"Yehia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Mohammed Adel","family":"Arafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"1727_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.thromres.2024.03.008","volume":"236","author":"JY Hur","year":"2024","unstructured":"Hur JY, Choi N, Choi JH, Kim J, Won YW. Risk of thrombosis, hemorrhage and leukemic transformation in patients with myeloproliferative neoplasms: a nationwide longitudinal cohort study. Thromb Res. 2024;236:209\u201319. https:\/\/doi.org\/10.1016\/j.thromres.2024.03.008.","journal-title":"Thromb Res"},{"issue":"1","key":"1727_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00277-020-04304-y","volume":"100","author":"DCA Molitor","year":"2021","unstructured":"Molitor DCA, Boor PPC, Buness A, Schneider RK, Teichmann LL, K\u00f6rber RM, et al. Macrophage frequency in the bone marrow correlates with morphologic subtype of myeloproliferative neoplasm. Ann Hematol. 2021;100(1):97\u2013104. https:\/\/doi.org\/10.1007\/s00277-020-04304-y.","journal-title":"Ann Hematol"},{"key":"1727_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.906698","volume":"12","author":"L Varricchio","year":"2022","unstructured":"Varricchio L, Hoffman R. Megakaryocytes are regulators of the tumor microenvironment and malignant hematopoietic progenitor cells in myelofibrosis. Front Oncol. 2022;12:906698. https:\/\/doi.org\/10.3389\/fonc.2022.906698.","journal-title":"Front Oncol"},{"issue":"14","key":"1727_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143597","volume":"13","author":"E Cencini","year":"2021","unstructured":"Cencini E, Fabbri A, Sicuranza A, Gozzetti A, Bocchia M. The role of tumor-associated macrophages in hematologic malignancies. Cancers (Basel). 2021;13(14):3597. https:\/\/doi.org\/10.3390\/cancers13143597.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"1727_CR5","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/liv.15843","volume":"44","author":"A Kandeel","year":"2024","unstructured":"Kandeel A, Fahim M, Abukamar S, BahaaEldin H, Abuelsood H, Samy S, et al. Evidence for the elimination of viral hepatitis B and C in Egypt: results of a nationwide survey in 2022. Liver Int. 2024;44(4):955\u201365. https:\/\/doi.org\/10.1111\/liv.15843.","journal-title":"Liver Int"},{"issue":"1","key":"1727_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-288","volume":"13","author":"YA Mohamoud","year":"2013","unstructured":"Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis. 2013;13(1):288. https:\/\/doi.org\/10.1186\/1471-2334-13-288.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"1727_CR7","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.3892\/etm.2018.5959","volume":"15","author":"K Minami","year":"2018","unstructured":"Minami K, Hiwatashi K, Ueno S, Sakoda M, Iino S, Okumura H, et al. Prognostic significance of CD68, CD163 and folate receptor-\u03b2 positive macrophages in hepatocellular carcinoma. Exp Ther Med. 2018;15(5):4465\u201376. https:\/\/doi.org\/10.3892\/etm.2018.5959.","journal-title":"Exp Ther Med"},{"issue":"7","key":"1727_CR8","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00277-023-05232-9","volume":"102","author":"W Fan","year":"2023","unstructured":"Fan W, Cao W, Shi J, Gao F, Wang M, Xu L, et al. Contributions of bone marrow monocytes\/macrophages in myeloproliferative neoplasms with JAK2V617F mutation. Ann Hematol. 2023;102(7):1745\u201359. https:\/\/doi.org\/10.1007\/s00277-023-05232-9.","journal-title":"Ann Hematol"},{"issue":"7","key":"1727_CR9","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/cas.12167","volume":"104","author":"Y Komohara","year":"2013","unstructured":"Komohara Y, Niino D, Saito Y, Ohnishi K, Horlad H, Ohshima K, et al. Clinical significance of CD163\u2009+\u2009tumor-associated macrophages in patients with adult T\u2010cell leukemia\/lymphoma. Cancer Sci. 2013;104(7):945\u201351. https:\/\/doi.org\/10.1111\/cas.12167.","journal-title":"Cancer Sci"},{"issue":"4","key":"1727_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1412910","volume":"7","author":"X Yang","year":"2018","unstructured":"Yang X, Feng W, Wang R, Yang F, Wang L, Chen S, et al. Repolarizing heterogeneous leukemia-associated macrophages with more M1 characteristics eliminates their pro-leukemic effects. Oncoimmunology. 2018;7(4):e1412910. https:\/\/doi.org\/10.1080\/2162402X.2017.1412910.","journal-title":"Oncoimmunology"},{"issue":"1","key":"1727_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1683347","volume":"9","author":"ZJ Xu","year":"2020","unstructured":"Xu ZJ, Gu Y, Wang CZ, Jin Y, Wen XM, Ma JC, et al. The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia. Oncoimmunology. 2020;9(1):1683347. https:\/\/doi.org\/10.1080\/2162402X.2019.1683347.","journal-title":"Oncoimmunology"},{"key":"1727_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00277-020-03912-y","volume":"99","author":"JX Song","year":"2020","unstructured":"Song JX, Wen Y, Li RW, Dong T, Tang YF, Zhang JJ, et al. Phenotypic characterization of macrophages in the BMB sample of human acute leukemia. Ann Hematol. 2020;99:539\u201347. https:\/\/doi.org\/10.1007\/s00277-020-03912-y.","journal-title":"Ann Hematol"},{"issue":"14","key":"1727_CR13","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.7150\/jca.30102","volume":"10","author":"H Wang","year":"2019","unstructured":"Wang H, Hu WM, Xia ZJ, Liang Y, Lu Y, Lin SX, et al. High numbers of CD163\u2009+\u2009tumor-associated macrophages correlate with poor prognosis in multiple myeloma patients receiving bortezomib-based regimens. J Cancer. 2019;10(14):3239\u201345. https:\/\/doi.org\/10.7150\/jca.30102.","journal-title":"J Cancer"},{"issue":"68","key":"1727_CR14","doi-asserted-by":"publisher","first-page":"112685","DOI":"10.18632\/oncotarget.22340","volume":"8","author":"X Chen","year":"2017","unstructured":"Chen X, Chen J, Zhang W, Sun R, Liu T, Zheng Y, et al. Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma. Oncotarget. 2017;8(68):112685\u201396. https:\/\/doi.org\/10.18632\/oncotarget.22340.","journal-title":"Oncotarget"},{"key":"1727_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00277-012-1652-6","volume":"92","author":"E Suyan\u0131","year":"2013","unstructured":"Suyan\u0131 E, Sucak GT, Aky\u00fcrek N, \u015eahin S, Baysal NA, Ya\u011fc\u0131 M, et al. Tumor-associated macrophages as a prognostic parameter in multiple myeloma. Ann Hematol. 2013;92:669\u201377. https:\/\/doi.org\/10.1007\/s00277-012-1652-6.","journal-title":"Ann Hematol"},{"issue":"4","key":"1727_CR16","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/leu.2015.191","volume":"30","author":"S Panchabhai","year":"2016","unstructured":"Panchabhai S, Kelemen K, Ahmann G, Sebastian S, Mantei J, Fonseca R. Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma. Leukemia. 2016;30(4):951\u20134. https:\/\/doi.org\/10.1038\/leu.2015.191.","journal-title":"Leukemia"},{"issue":"1","key":"1727_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ejh.12296","volume":"93","author":"MN Andersen","year":"2014","unstructured":"Andersen MN, Abildgaard N, Maniecki MB, M\u00f8ller HJ, Andersen NF. Monocyte\/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma. Eur J Haematol. 2014;93(1):41\u20137. https:\/\/doi.org\/10.1111\/ejh.12296.","journal-title":"Eur J Haematol"},{"issue":"1","key":"1727_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66010-z","volume":"10","author":"L Werner","year":"2020","unstructured":"Werner L, Dreyer JH, Hartmann D, Barros MH, B\u00fcttner-Herold M, Grittner U, et al. Tumor-associated macrophages in classical hodgkin lymphoma: hormetic relationship to outcome. Sci Rep. 2020;10(1):9410. https:\/\/doi.org\/10.1038\/s41598-020-66010-z.","journal-title":"Sci Rep"},{"issue":"4","key":"1727_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040877","volume":"12","author":"K Karihtala","year":"2020","unstructured":"Karihtala K, Leivonen SK, Br\u00fcck O, Karjalainen-Lindsberg ML, Mustjoki S, Pellinen T, et al. Prognostic impact of tumor-associated macrophages on survival is checkpoint dependent in classical Hodgkin lymphoma. Cancers (Basel). 2020;12(4):877. https:\/\/doi.org\/10.3390\/cancers12040877.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1727_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1309\/AJCP61TLMXLSLJYS","volume":"141","author":"JL Klein","year":"2014","unstructured":"Klein JL, Nguyen TT, Bien-Willner GA, Chen L, Foyil KV, Bartlett NL, et al. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical hodgkin lymphoma. Am J Clin Pathol. 2014;141(3):381\u20137. https:\/\/doi.org\/10.1309\/AJCP61TLMXLSLJYS.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"1727_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1600-0609.2011.01731.x","volume":"88","author":"DH Yoon","year":"2012","unstructured":"Yoon DH, Koh YW, Kang HJ, Kim S, Park CS, Lee SW, et al. CD68 and CD163 as prognostic factors for Korean patients with hodgkin lymphoma. Eur J Haematol. 2012;88(4):292\u2013305. https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01731.x.","journal-title":"Eur J Haematol"},{"key":"1727_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-016-0711-6","volume":"14","author":"B Guo","year":"2016","unstructured":"Guo B, Cen H, Tan X, Ke Q. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical hodgkin lymphoma. BMC Med. 2016;14:1. https:\/\/doi.org\/10.1186\/s12916-016-0711-6.","journal-title":"BMC Med"},{"issue":"2","key":"1727_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3324\/haematol.2014.113472","volume":"100","author":"S Riihij\u00e4rvi","year":"2015","unstructured":"Riihij\u00e4rvi S, Fiskvik I, Taskinen M, Vajavaara H, Tikkala M, Yri O, et al. Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a nordic phase II trial. Haematologica. 2015;100(2):238\u201345. https:\/\/doi.org\/10.3324\/haematol.2014.113472.","journal-title":"Haematologica"},{"issue":"2","key":"1727_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/hon.2142","volume":"33","author":"F Marchesi","year":"2015","unstructured":"Marchesi F, Cirillo M, Bianchi A, Gately M, Olimpieri OM, Cerchiara E, et al. High density of CD68+\/CD163\u2009+\u2009tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma. Hematol Oncol. 2015;33(2):110\u20132. https:\/\/doi.org\/10.1002\/hon.2142.","journal-title":"Hematol Oncol"},{"issue":"1","key":"1727_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41375-025-02569-8","volume":"39","author":"F Perner","year":"2025","unstructured":"Perner F, Pahl HL, Zeiser R, Heidel FH. Malignant JAK-signaling: at the interface of inflammation and malignant transformation. Leukemia. 2025;39(1):157\u201364. https:\/\/doi.org\/10.1038\/s41375-025-02569-8.","journal-title":"Leukemia"},{"key":"1727_CR26","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/367284","volume":"2011","author":"AJ Chu","year":"2011","unstructured":"Chu AJ. Tissue factor, blood coagulation, and beyond: an overview. Int J Inflamm. 2011;2011:367284. https:\/\/doi.org\/10.4061\/2011\/367284.","journal-title":"Int J Inflamm"},{"issue":"6","key":"1727_CR27","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/jleukbio\/qiae071","volume":"115","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang Y, Huang G, Wu S, Liu X, Zheng B, et al. The role of leukocytes in myeloproliferative neoplasm thromboinflammation. J Leukoc Biol. 2024;115(6):1020\u201330. https:\/\/doi.org\/10.1093\/jleukbio\/qiae071.","journal-title":"J Leukoc Biol"},{"issue":"11","key":"1727_CR28","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1253\/circj.CJ-15-0394","volume":"79","author":"N Okuyama","year":"2015","unstructured":"Okuyama N, Matsuda S, Yamashita A, Goto S, Liang M, Imamura H, et al. Human coronary thrombus formation is associated with degree of plaque disruption and expression of tissue factor and hexokinase II. Circ J. 2015;79(11):2430\u20138. https:\/\/doi.org\/10.1253\/circj.CJ-15-0394.","journal-title":"Circ J"},{"issue":"1","key":"1727_CR29","doi-asserted-by":"publisher","first-page":"e0316474","DOI":"10.1371\/journal.pone.0316474","volume":"20","author":"K Maekawa","year":"2025","unstructured":"Maekawa K, Nakamura E, Saito Y, Matsuura Y, Gi T, Hayashi T, et al. Inflammatory stimuli and hypoxia on atherosclerotic plaque thrombogenicity: linking macrophage tissue factor and Glycolysis. PLoS ONE. 2025;20(1):e0316474. https:\/\/doi.org\/10.1371\/journal.pone.0316474.","journal-title":"PLoS ONE"},{"issue":"436","key":"1727_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan8292","volume":"10","author":"O Wolach","year":"2018","unstructured":"Wolach O, Sellar RS, Martinod K, Cherpokova D, McConkey M, Chappell RJ, et al. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms. Sci Transl Med. 2018;10(436):eaan8292. https:\/\/doi.org\/10.1126\/scitranslmed.aan8292.","journal-title":"Sci Transl Med"},{"key":"1727_CR31","doi-asserted-by":"publisher","first-page":"38738","DOI":"10.1038\/srep38738","volume":"6","author":"CP Marin Oyarz\u00fan","year":"2016","unstructured":"Marin Oyarz\u00fan CP, Carestia A, Lev PR, Glembotsky AC, Machlus KR, Italiano JE Jr, et al. Neutrophil extracellular trap formation and Circulating nucleosomes in patients with chronic myeloproliferative neoplasms. Sci Rep. 2016;6:38738. https:\/\/doi.org\/10.1038\/srep38738.","journal-title":"Sci Rep"},{"issue":"4","key":"1727_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s11899-021-00630-8","volume":"16","author":"BN Reeves","year":"2021","unstructured":"Reeves BN, Beckman JD. Novel pathophysiological mechanisms of thrombosis in myeloproliferative neoplasms. Curr Hematol Malig Rep. 2021;16(4):304\u201313. https:\/\/doi.org\/10.1007\/s11899-021-00630-8.","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"1727_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3324\/haematol.2018.210005","volume":"104","author":"M Bar-Natan","year":"2019","unstructured":"Bar-Natan M, Hoffman R. New insights into the causes of thrombotic events in patients with myeloproliferative neoplasms Raise the possibility of novel therapeutic approaches. Haematologica. 2019;104(1):1\u20134. https:\/\/doi.org\/10.3324\/haematol.2018.210005.","journal-title":"Haematologica"},{"key":"1727_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1196817","volume":"13","author":"S Hermouet","year":"2023","unstructured":"Hermouet S. Mutations, inflammation and phenotype of myeloproliferative neoplasms. Front Oncol. 2023;13:1196817. https:\/\/doi.org\/10.3389\/fonc.2023.1196817.","journal-title":"Front Oncol"},{"issue":"13","key":"1727_CR35","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","volume":"122","author":"T Barbui","year":"2013","unstructured":"Barbui T, Finazzi G, Falanga A. Myeloproliferative neoplasms and thrombosis. Blood. 2013;122(13):2176\u201384. https:\/\/doi.org\/10.1182\/blood-2013-03-460154.","journal-title":"Blood"},{"issue":"1","key":"1727_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/453020","volume":"2015","author":"VP \u010coki\u0107","year":"2015","unstructured":"\u010coki\u0107 VP, Mitrovi\u0107-Ajti\u0107 O, Beleslin-\u010coki\u0107 BB, Markovi\u0107 D, Bua\u010d M, Dikli\u0107 M, et al. Proinflammatory cytokine IL-6 and JAK\u2010STAT signaling pathway in myeloproliferative neoplasms. Mediators Inflamm. 2015;2015(1):453020. https:\/\/doi.org\/10.1155\/2015\/453020.","journal-title":"Mediators Inflamm"},{"key":"1727_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02093","volume":"11","author":"JS Jutzi","year":"2020","unstructured":"Jutzi JS, Mullally A. Remodeling the bone marrow microenvironment\u2013a proposal for targeting pro-inflammatory contributors in MPN. Front Immunol. 2020;11:2093. https:\/\/doi.org\/10.3389\/fimmu.2020.02093.","journal-title":"Front Immunol"},{"key":"1727_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01186","volume":"9","author":"EM Elli","year":"2019","unstructured":"Elli EM, Barat\u00e8 C, Mendicino F, Palandri F, Palumbo GA. Mechanisms underlying the anti-inflammatory and immunosuppressive activity of ruxolitinib. Front Oncol. 2019;9:1186. https:\/\/doi.org\/10.3389\/fonc.2019.01186.","journal-title":"Front Oncol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01727-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01727-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01727-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T20:04:17Z","timestamp":1763150657000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01727-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1727"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01727-x","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Research and Ethics Committee of Kasr Al-Ainy School of Medicine, Cairo University (Code N-34-2025). All procedures performed involving human participants were per the ethical standards of the institutional research committee and with the Helsinki Declaration and its later amendments. Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":".","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}